---
layout: post
title: "ğŸš€ Redefining Drug-Likeness with AI: ICML & ISMB Presentations Coming Up! ğŸ’Š"
date: 2025-6-29 16:11:00-0400
inline: false
related_posts: false
---

### â€œCan this molecule become a drug?â€ ğŸ¤”
Thatâ€™s the ultimate question in drug discovery, but for over 20 years, weâ€™ve been relying on Lipinskiâ€™s Rule of 5 and other old heuristics.

âœ¨ This July, weâ€™re bringing AI to redefine drug-likeness at two of the worldâ€™s top AI & bioinformatics conferences:

#### ğŸ“ ICML 2025 (Vancouver, July 15)
**â€œBounDr.E: Predicting Drug-likeness via Biomedical Knowledge Alignment and EM-like One-Class Boundary Optimization.â€**
We propose an EM-like one-class boundary optimization approach, aligning biomedical knowledge to predict drug-likeness without heuristic rules.

#### ğŸ“ ISMB/ECCB 2025 (Liverpool, July 24)
**â€œADME-Drug-Likeness: Enriching Molecular Foundation Models via Pharmacokinetics-Guided Multi-Task Learning for Drug-likeness Prediction.â€**
We integrate ADME (absorption, distribution, metabolism, excretion) properties into molecular foundation models to enhance the interpretability and predictive power of drug-likeness.

Our mission at AIGENDRUG and SNU (Prof. Sun Kimâ€™s lab) is to bring data-driven, quantitative definitions of â€œdrug-likenessâ€ into the early stages of drug discovery, moving beyond rules, and enabling smarter drug design. ğŸ’¡

Looking forward to sharing these ideas with the global AI and bioinformatics community this summer! ğŸŒğŸ§¬